Source:http://linkedlifedata.com/resource/pubmed/id/10835504
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-7-18
|
pubmed:abstractText |
We previously found that the efficacy of radioimmunotherapy (RIT) with (131)I-A7, an IgG(1) against M(r) 45000 glycoprotein on colon cancer, was enhanced by local hyperthermia (HT) or chemotherapy with 5-fluorouracil (5-FU). In this study, we aimed to further enhance its efficacy by combining these three modalities. Human colon cancer xenografts (146 x 12 mm(3)) in Balb / c nu / nu female mice were treated with 9.25 MBq (131)I-A7 i.v. combined with HT (43 degrees C for 1 h) and 5-FU (30 mg / kg / day i.p. for 5 days). Tumor growth delay, (Tq(treated) - Tq(control) )/ Tq(control) where Tq is tumor quadrupling time, in mice treated with RIT + HT + 5-FU was improved to 12.7 from 5.90, 7.55 and 10.1 with RIT alone, RIT + 5-FU and RIT + HT, respectively. Complete response was observed in 4 out of 8 tumors with RIT + HT + 5-FU and 3 out of 10 with RIT + HT. No tumor showed complete response with RIT + 5-FU or RIT alone. 5-FU slightly increased myelotoxicity of RIT, but HT did not affect it. Body weight loss was not enhanced by the combination. These results indicate that the combination of three modalities is a feasible approach to enhance the antitumor efficacy of RIT without serious increase of toxicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0910-5050
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
573-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10835504-Animals,
pubmed-meshheading:10835504-Antibodies, Monoclonal,
pubmed-meshheading:10835504-Antimetabolites, Antineoplastic,
pubmed-meshheading:10835504-Body Weight,
pubmed-meshheading:10835504-Combined Modality Therapy,
pubmed-meshheading:10835504-Feasibility Studies,
pubmed-meshheading:10835504-Female,
pubmed-meshheading:10835504-Fluorouracil,
pubmed-meshheading:10835504-Hyperthermia, Induced,
pubmed-meshheading:10835504-Immunoglobulin G,
pubmed-meshheading:10835504-Mice,
pubmed-meshheading:10835504-Mice, Inbred BALB C,
pubmed-meshheading:10835504-Mice, Nude,
pubmed-meshheading:10835504-Neoplasms,
pubmed-meshheading:10835504-Radioimmunotherapy,
pubmed-meshheading:10835504-Transplantation, Heterologous
|
pubmed:year |
2000
|
pubmed:articleTitle |
Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model.
|
pubmed:affiliation |
Department of Nuclear Medicine, Kanazawa University School of Medicine, 13-1 Takaramachi, Kanazawa 920-8640, Japan. kinuya@med. kanazawa-u.ac.jp.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|